Attached files
| file | filename |
|---|---|
| 8-K - APTARGROUP, INC. 8-K - APTARGROUP INC | a6686459.htm |
Exhibit 99.1
Segment information for the years ended 2010 and 2009
(Amounts in thousands, unaudited information)
|
2010
|
2009
|
|||||||
| Sales: | ||||||||
|
Beauty + Home
|
$ | 1,391,335 | $ | 1,204,253 | ||||
|
Pharma
|
476,376 | 451,175 | ||||||
|
Food + Beverage
|
222,629 | 199,767 | ||||||
|
Other
|
170 | 195 | ||||||
|
Total Sales
|
$ | 2,090,510 | $ | 1,855,390 | ||||
| Less: Intersegment Sales: | ||||||||
|
Beauty + Home
|
$ | 11,270 | $ | 11,078 | ||||
|
Pharma
|
129 | 209 | ||||||
|
Food + Beverage
|
2,227 | 2,294 | ||||||
|
Other
|
165 | 193 | ||||||
|
Total Intersegment Sales
|
$ | 13,791 | $ | 13,774 | ||||
| Net Sales: | ||||||||
|
Beauty + Home
|
$ | 1,380,065 | $ | 1,193,175 | ||||
|
Pharma
|
476,247 | 450,966 | ||||||
|
Food + Beverage
|
220,402 | 197,473 | ||||||
|
Other
|
5 | 2 | ||||||
|
Total Net Sales
|
$ | 2,076,719 | $ | 1,841,616 | ||||
| Segment Income (1): | ||||||||
|
Beauty + Home
|
$ | 132,172 | $ | 68,230 | ||||
|
Pharma
|
134,531 | 128,006 | ||||||
|
Food + Beverage
|
27,796 | 27,540 | ||||||
|
Corporate and Other
|
(28,991 | ) | (26,566 | ) | ||||
|
Income before Interest and Taxes
|
$ | 265,508 | $ | 197,210 | ||||
| Interest Expense, net | (11,123 | ) | (13,152 | ) | ||||
|
Income before Income Taxes
|
$ | 254,385 | $ | 184,058 | ||||
| Depreciation and Amortization: | ||||||||
|
Beauty + Home
|
$ | 91,891 | $ | 93,903 | ||||
|
Pharma
|
26,638 | 24,608 | ||||||
|
Food + Beverage
|
12,065 | 12,245 | ||||||
|
Corporate and Other
|
2,365 | 2,257 | ||||||
|
Total Depreciation and Amortization
|
$ | 132,959 | $ | 133,013 | ||||
| Capital Expenditures: | ||||||||
|
Beauty + Home
|
$ | 75,659 | $ | 77,280 | ||||
|
Pharma
|
19,401 | 26,839 | ||||||
|
Food + Beverage
|
15,421 | 15,377 | ||||||
|
Corporate and Other
|
8,323 | 25,430 | ||||||
|
Total Capital Expenditures
|
$ | 118,804 | $ | 144,926 | ||||
| Total Assets: | ||||||||
|
Beauty + Home
|
$ | 1,180,928 | $ | 1,127,385 | ||||
|
Pharma
|
354,512 | 362,722 | ||||||
|
Food + Beverage
|
140,931 | 136,453 | ||||||
|
Corporate and Other
|
356,347 | 329,633 | ||||||
|
Total Assets
|
$ | 2,032,718 | $ | 1,956,193 | ||||
(1) The Company evaluates performance of its business units and allocates resources based upon segment income. Segment income is defined as earnings before net interest expense, certain corporate expenses and income taxes. Included in the segment income figures reported above are consolidation/severance expenses for the twelve months ended December 31, 2010 and 2009 as follows:
| CONSOLIDATION/SEVERANCE EXPENSES | ||||||||
|
Beauty + Home
|
$ | (46 | ) | $ | (4,030 | ) | ||
|
Pharma
|
-- | (433 | ) | |||||
|
Food + Beverage
|
(47 | ) | (3,100 | ) | ||||
|
Total Consolidation/Severance Expenses
|
$ | (93 | ) | $ | (7,563 | ) | ||
Also included in the segment income figures reported above are the following stock option expenses:
|
2010
|
2009
|
|||||||
| STOCK OPTION EXPENSES | ||||||||
|
Beauty + Home
|
$ | (4,355 | ) | $ | (3,993 | ) | ||
|
Pharma
|
(1,384 | ) | (1,306 | ) | ||||
|
Food + Beverage
|
(1,149 | ) | (884 | ) | ||||
|
Corporate and Other
|
(4,327 | ) | 3,579 | ) | ||||
|
Total Stock Option Expenses
|
$ | (11,215 | ) | $ | (9,762 | ) | ||
Segment information for the quarters ended March 31, June 30, September 30, and
December 31, 2010
(Amounts in thousands, unaudited information)
| 1Q 2010 | 2Q 2010 | 3Q 2010 | 4Q 2010 |
Total for 2010
|
||||||||||||||||
| Sales: | ||||||||||||||||||||
|
Beauty + Home
|
$ | 342,591 | $ | 346,323 | $ | 348,858 | $ | 353,563 | $ | 1,391,335 | ||||||||||
|
Pharma
|
113,489 | 117,857 | 117,543 | 127,487 | 476,376 | |||||||||||||||
|
Food + Beverage
|
53,324 | 62,095 | 54,295 | 52,915 | 222,629 | |||||||||||||||
|
Other
|
25 | 46 | 38 | 61 | 170 | |||||||||||||||
|
Total Sales
|
509,429 | 526,321 | 520,734 | 534,026 | 2,090,510 | |||||||||||||||
| Less: Intersegment Sales: | ||||||||||||||||||||
|
Beauty + Home
|
$ | 3,182 | $ | 2,489 | $ | 2,750 | $ | 2,849 | $ | 11,270 | ||||||||||
|
Pharma
|
48 | 33 | 23 | 25 | 129 | |||||||||||||||
|
Food + Beverage
|
705 | 830 | 387 | 305 | 2,227 | |||||||||||||||
|
Other
|
25 | 46 | 37 | 57 | 165 | |||||||||||||||
|
Total Intersegment Sales
|
3,960 | 3,398 | 3,197 | 3,236 | 13,791 | |||||||||||||||
| Net Sales: | ||||||||||||||||||||
|
Beauty + Home
|
$ | 339,409 | $ | 343,834 | $ | 346,108 | $ | 350,714 | $ | 1,380,065 | ||||||||||
|
Pharma
|
113,441 | 117,824 | 117,520 | 127,462 | 476,247 | |||||||||||||||
|
Food + Beverage
|
52,619 | 61,265 | 53,908 | 52,610 | 220,402 | |||||||||||||||
|
Other
|
0 | 0 | 1 | 4 | 5 | |||||||||||||||
|
Total Net Sales
|
505,469 | 522,923 | 517,537 | 530,790 | 2,076,719 | |||||||||||||||
| Segment Income: | ||||||||||||||||||||
|
Beauty + Home
|
$ | 31,111 | $ | 35,881 | $ | 34,324 | $ | 30,856 | $ | 132,172 | ||||||||||
|
Pharma
|
30,646 | 32,773 | 35,091 | 36,021 | 134,531 | |||||||||||||||
|
Food + Beverage
|
7,615 | 10,700 | 6,443 | 3,038 | 27,796 | |||||||||||||||
|
Corporate & Other
|
(8,748 | ) | (6,441 | ) | (5,009 | ) | (8,793 | ) | (28,991 | ) | ||||||||||
|
Income before interest and taxes
|
$ | 60,624 | $ | 72,913 | $ | 70,849 | $ | 61,122 | $ | 265,508 | ||||||||||
| Interest expense, net | (2,706 | ) | (3,123 | ) | (2,703 | ) | (2,591 | ) | (11,123 | ) | ||||||||||
| Income before Income Taxes | $ | 57,918 | $ | 69,790 | $ | 68,146 | $ | 58,531 | $ | 254,385 | ||||||||||
(1) The Company evaluates performance of its business units and allocates resources based upon segment income. Segment income is defined as earnings before net interest expense, certain corporate expenses and income taxes. Included in the segment income figures reported above are consolidation/severance expenses for the twelve months ended December 31, 2010 and 2009 as follows:
| CONSOLIDATION/SEVERANCE EXPENSES | ||||||||||||||||||||
|
Beauty + Home
|
$ | -- | $ | -- | $ | (444 | ) | $ | 398 | $ | (46 | ) | ||||||||
|
Pharma
|
-- | -- | -- | -- | -- | |||||||||||||||
|
Food + Beverage
|
-- | -- | 63 | (110 | ) | (47 | ) | |||||||||||||
|
Total Consolidation/Severance Expenses
|
$ | -- | $ | -- | $ | (381 | ) | $ | 288 | $ | (93 | ) | ||||||||
Also included in the segment income figures reported above are the following stock option expenses:
| STOCK OPTION EXPENSES | ||||||||||||||||||||
|
Beauty + Home
|
$ | (1,985 | ) | $ | (984 | ) | $ | (800 | ) | $ | (586 | ) | $ | (4,355 | ) | |||||
|
Pharma
|
(504 | ) | (299 | ) | (299 | ) | (282 | ) | (1,384 | ) | ||||||||||
|
Food + Beverage
|
(712 | ) | (146 | ) | (145 | ) | (146 | ) | (1,149 | ) | ||||||||||
|
Corporate and Other
|
(2,780 | ) | (788 | ) | (376 | ) | (383 | ) | (4,327 | ) | ||||||||||
|
Total Stock Option Expenses
|
$ | (5,981 | ) | $ | (2,217 | ) | $ | (1,620 | ) | $ | (1,397 | ) | $ | (11,215 | ) | |||||